Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles.
This year, the Pharmapack Innovation Awards were judged with different criteria from previous editions – namely, the inclusion of sustainability considerations in all categories. This change marks an important shift in the weight ESG principles carry in pharmaceutical operations, something to continue into next editions of CPHI events.
With two categories encompassing Exhibitor Innovation and Health Product Innovation, this year’s Pharmapack Awards celebrate the pharmaceutical packaging and drug delivery sectors like none other!
Packaging Innovation
The Packaging Innovation award, which recognises advancements in primary, secondary, and tertiary pharmaceutical packaging, was awarded to Nissha Europe GmbH for their Pulp-Injection Autoinjector Component. As a device component, Pulp-Injection was developed to be suitable for most device components and secondary packaging, and for use in external autoinjector caps and closures with thread structures.
Highly Commended
The jury also recommended Coradin’s GREENIS dispenser for a high commendation with their intuitive dropper providing improved consumer ergonomics and distribution resistance for fluid-type skin care treatments.
Start-up Innovation
Pharmapack 2024 saw a record 20 start-ups participating in this year’s Start-Up Pitches. The jury thus saw fit to deliver a Start-up Innovation award in recognition of the companies at the very beginning of their innovative careers. This year’s Start-up Innovation award was bestowed to Capa Valve Ltd for their Capa Valve system that allows for the compartmentalisation of a standard syringe into a dual chamber device. Because of its installation in two parts, it is suitable for prefilled applications, the premixing of two liquids, the dispensing of two separate liquids, or the premixing of a liquid diluent and a solid drug.
Patient-centric Design
Dr Ferrer Biopharma’s GentleMist Technology was awarded the Patient-centric Design award for the revolutionary method of intranasal drug delivery, with enhanced comfort for targeted drug delivery. The nozzle utilises enhanced fluid dynamics to reduce pressure-associated discomfort when using a nasal spray.
Eco-design
For the Eco-design Award, Rotor Print’s Recyclable Stick was recognised for its focus on sustainable packaging that also prioritises barrier properties, good sealing properties, and good machine performance. The recyclable sticks provides a reliable packaging mono material to ensure recyclability of the product. While sustainability considerations were taken into account for each category, it is important to recognise innovative healthcare products leading the way in prioritising sustainability and ESG principles.
Highly Commended
The jury also highly commended Klim-Loc Medical’s medical vial and cap system packaged during the Fill and Finish process, delivered completely needleless. The reduction in needles allows for a decrease in packaging and waste, injury prevention, and fully recyclable vial systems.
Congratulations to all those nominated and to our award winners!
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance